Helmut Dolznig

11PUBLICATIONS
58CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsSoftware quality, processes and metricsTumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Dec 30, 2025
The Role of Prostaglandins as Major Inflammatory Mediators in Colorectal Cancer.

Mario Macia Guardado, Valentina Lutz, Markus Hengstschläger

|Nov 05, 2025
DLL1-responsive PD-L1<sup>+</sup> tumor-associated macrophages promote endocrine resistance in breast cancer.

Shailesh Singh, Claudia Weindorfer, Ajeya Nandi

|Jul 17, 2023
IL1R1<sup>+</sup> cancer-associated fibroblasts drive tumor development and immunosuppression in colorectal cancer.

E Koncina, M Nurmik, V I Pozdeev

|Apr 05, 2023
RAF1 contributes to cell proliferation and STAT3 activation in colorectal cancer independently of microsatellite and KRAS status.

Coralie Dorard, Claire Madry, Olivier Buhard

|Feb 05, 2022
Tumour cell apoptosis modulates the colorectal cancer immune microenvironment via interleukin-8-dependent neutrophil recruitment.

Vanessa Schimek, Katharina Strasser, Andrea Beer

|Nov 02, 2021
MISpheroID: a knowledgebase and transparency tool for minimum information in spheroid identity.

Arne Peirsman, Eva Blondeel, Tasdiq Ahmed

Pageof 2

Frequent Collaborators

1 joint publications

R Moriggl

1 joint publications

E Koncina

1 joint publications

C Gilson

1 joint publications

A Gaigneaux